Jonathan Passeri

6.7k total citations · 4 hit papers
73 papers, 4.6k citations indexed

About

Jonathan Passeri is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jonathan Passeri has authored 73 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cardiology and Cardiovascular Medicine, 28 papers in Epidemiology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jonathan Passeri's work include Cardiac Valve Diseases and Treatments (37 papers), Infective Endocarditis Diagnosis and Management (24 papers) and Cardiac Imaging and Diagnostics (14 papers). Jonathan Passeri is often cited by papers focused on Cardiac Valve Diseases and Treatments (37 papers), Infective Endocarditis Diagnosis and Management (24 papers) and Cardiac Imaging and Diagnostics (14 papers). Jonathan Passeri collaborates with scholars based in United States, Canada and Spain. Jonathan Passeri's co-authors include Jeffrey M. Isner, Marianne Kearney, Michael H. Picard, Marielle Scherrer‐Crosbie, James L. Januzzi, Igal A. Sebag, Irene Kuter, Robert E. Gerszten, Victor Cohen and Heloisa Sawaya and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Jonathan Passeri

68 papers receiving 4.5k citations

Hit Papers

Apoptosis in Human Athero... 1995 2026 2005 2015 1995 2012 2011 2013 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jonathan Passeri 2.7k 1.1k 920 876 846 73 4.6k
Albrecht Elsässer 3.0k 1.1× 1.9k 1.6× 2.3k 2.5× 819 0.9× 222 0.3× 170 5.9k
Robert E. Stroud 2.2k 0.8× 878 0.8× 980 1.1× 238 0.3× 443 0.5× 102 3.7k
Risto Kerkelä 2.2k 0.8× 2.0k 1.7× 536 0.6× 187 0.2× 1.1k 1.3× 86 4.6k
Michael J.B. Kutryk 1.3k 0.5× 1.5k 1.3× 1.7k 1.9× 321 0.4× 285 0.3× 81 4.1k
Jeffrey A. Jones 782 0.3× 1.3k 1.1× 656 0.7× 293 0.3× 750 0.9× 130 4.4k
Tuomas T. Rissanen 1.2k 0.4× 2.1k 1.8× 1.7k 1.8× 452 0.5× 657 0.8× 82 4.1k
Dirk Walter 1.3k 0.5× 2.7k 2.4× 2.5k 2.7× 291 0.3× 984 1.2× 91 6.2k
Hiroyuki Hao 800 0.3× 991 0.9× 1.6k 1.7× 375 0.4× 226 0.3× 139 3.5k
Thierry Couffinhal 766 0.3× 2.4k 2.1× 1.2k 1.3× 356 0.4× 355 0.4× 139 4.7k
John J. López 1.3k 0.5× 1.5k 1.3× 1.6k 1.7× 572 0.7× 195 0.2× 93 3.5k

Countries citing papers authored by Jonathan Passeri

Since Specialization
Citations

This map shows the geographic impact of Jonathan Passeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Passeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Passeri more than expected).

Fields of papers citing papers by Jonathan Passeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Passeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Passeri. The network helps show where Jonathan Passeri may publish in the future.

Co-authorship network of co-authors of Jonathan Passeri

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Passeri. A scholar is included among the top collaborators of Jonathan Passeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Passeri. Jonathan Passeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dahan, Shani, Jacob P. Dal‐Bianco, Ygal Plakht, et al.. (2025). Severe Mitral Regurgitation in Paradoxical Low-Flow, Low-Gradient Severe Aortic Stenosis. Circulation Cardiovascular Imaging. 18(5). e017598–e017598.
2.
Gupta, Tanush, Nilay Patel, Rahul Sakhuja, et al.. (2024). Outcomes of Transcatheter Aortic Valve Replacement Using Third-Generation Balloon-Expandable Versus Self-Expanding Valves: A Meta-analysis. Journal of the Society for Cardiovascular Angiography & Interventions. 3(7). 102146–102146. 3 indexed citations
3.
Khan, Omar, Chen Chen, Yuxi Liu, et al.. (2023). Impact of Moderate Aortic Stenosis in Patients With Heart Failure With Reduced Ejection Fraction. Journal of the American College of Cardiology. 81(13). 1235–1244. 18 indexed citations
4.
Bhardwaj, Bhaskar, Dhaval Kolte, Yanglu Zhao, et al.. (2022). Severity of and Recovery From Anemia After Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER Trials and Registries. Journal of the Society for Cardiovascular Angiography & Interventions. 2(1). 100531–100531. 1 indexed citations
5.
Li, Shawn X., Nilay Patel, Fritha Morrison, et al.. (2022). Trends in Utilization of Aortic Valve Replacement for Severe Aortic Stenosis. Journal of the American College of Cardiology. 79(9). 864–877. 46 indexed citations
6.
Langer, Nathaniel B., Ignacio Inglessis, Jonathan Passeri, et al.. (2022). Impact of Decision Aid on Decision-making of Patients With Severe Aortic Stenosis: Randomized Pilot Study. SHILAP Revista de lepidopterología. 1(2). 100025–100025. 2 indexed citations
7.
Tanguturi, Varsha K., Brian R. Lindman, Philippe Pîbarot, et al.. (2020). Managing Severe Aortic Stenosis in the COVID-19 Era. JACC: Cardiovascular Interventions. 13(16). 1937–1944. 13 indexed citations
8.
Kolte, Dhaval, Kevin F. Kennedy, Jonathan Passeri, Ignacio Inglessis, & Sammy Elmariah. (2020). Temporal Trends in Prevalence of Tricuspid Valve Disease in Hospitalized Patients in the United States. The American Journal of Cardiology. 125(12). 1879–1883. 5 indexed citations
9.
Kolte, Dhaval, Gus J. Vlahakes, Igor F. Palacios, et al.. (2019). Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients. Journal of the American College of Cardiology. 74(12). 1532–1540. 101 indexed citations
10.
Al‐Bawardy, Rasha, Sreekanth Vemulapalli, Vinod H. Thourani, et al.. (2018). TCT-802 Effects of Pulmonary Hypertension on Transcatheter Mitral Valve Repair Outcomes: Analysis of The STS/ACC TVT Registry. Journal of the American College of Cardiology. 72(13). B319–B320. 2 indexed citations
11.
Elmariah, Sammy, William F. Fearon, Ignacio Inglessis, et al.. (2017). Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction. JACC: Cardiovascular Interventions. 10(23). 2414–2422. 38 indexed citations
12.
Tan, Timothy C., Heloisa Sawaya, Igal A. Sebag, et al.. (2015). Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab. Journal of the American Society of Echocardiography. 28(5). 509–514. 49 indexed citations
13.
Elmariah, Sammy, Jonathan Passeri, Ignacio Inglessis, et al.. (2014). TCT-686 Impact of Left Ventricular Remodeling on Clinical Outcomes after TAVR: Insights from the PARTNER I Trial. Journal of the American College of Cardiology. 64(11). B200–B201. 1 indexed citations
14.
Fearon, William F., Sammy Elmariah, Tom McAndrew, et al.. (2013). TCT-112 Left Ventricular Ejection Fraction Improves Less after Trans-Apical Transcatheter Aortic Valve Replacement Compared to a Trans-Femoral Approach. Journal of the American College of Cardiology. 62(18). B36–B36. 1 indexed citations
15.
Ky, Bonnie, Mary Putt, Heloisa Sawaya, et al.. (2013). Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab. Journal of the American College of Cardiology. 63(8). 809–816. 398 indexed citations breakdown →
16.
Shimada, Yuichi J., Jonathan Passeri, Aaron L. Baggish, et al.. (2013). Effects of Losartan on Left Ventricular Hypertrophy and Fibrosis in Patients With Nonobstructive Hypertrophic Cardiomyopathy. JACC Heart Failure. 1(6). 480–487. 101 indexed citations
17.
Elmariah, Sammy, Dabit Arzamendi, Alexander Llanos, et al.. (2012). First Experience With Transcatheter Valve-In-Valve Implantation for a Stenotic Mitral Prosthesis Within the United States. JACC: Cardiovascular Interventions. 5(5). e13–e14. 7 indexed citations
18.
Johri, Amer M., Christian Witzke, Jorge Solı́s, et al.. (2011). Real-Time Three-Dimensional Transesophageal Echocardiography in Patients with Secundum Atrial Septal Defects: Outcomes following Transcatheter Closure. Journal of the American Society of Echocardiography. 24(4). 431–437. 38 indexed citations
19.
Sawaya, Heloisa, Igal A. Sebag, Juan Carlos Plana, et al.. (2011). Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients. The American Journal of Cardiology. 107(9). 1375–1380. 476 indexed citations breakdown →
20.
Asahara, Takayuki, Donghui Chen, Marianne Kearney, et al.. (1996). Accelerated re-endothelialization and reduced neointimal thickening following catheter transfer of phVEGF165. Journal of the American College of Cardiology. 27(2). 1–1. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026